Michael Vangedal
Papers
2
Total Citations
10
H-Index
2
About
Michael Vangedal is a Danish urological surgeon and researcher whose work centers on advancing surgical techniques for bladder cancer, particularly through robot-assisted radical cystectomy (RARC). His major contributions focus on optimizing perioperative and oncological outcomes in patients undergoing this complex procedure. In his landmark 11-year series, Vangedal demonstrated the feasibility and safety of RARC with intracorporeal urinary diversion, reporting robust outcomes that have informed clinical practice. His work has garnered significant attention, with his most cited papers each accumulating five citations—a notable impact for recent publications in a specialized field. Vangedal is also the lead investigator of the DaBlaCa-16 MOSAIC randomized controlled trial, which compares retrosigmoid versus conventional ileal conduit techniques to reduce ureteroenteric strictures, a common complication. This trial addresses a critical gap in urological surgery, aiming to improve patient quality of life. Vangedal’s research is characterized by its focus on evidence-based innovation, and his contributions are shaping the future of minimally invasive bladder cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2